Co-Diagnostics gains as it eliminates debt

Thinly traded nano cap Co-Diagnostics (NASDAQ:CODX) is up 44% premarket on increased volume on the heels of its sale of $3M of preferred stock at $1.20 per share. The transaction included the conversion of a $2M note to preferred shares, eliminating its debt.

https://seekingalpha.com/news/3427397-co-diagnostics-eliminates-debt-shares-44-percent-premarket